Bluegnome is supplying labs in over 15 countries with its 24sure product, which is directed at the investigation of the cause of recurrent miscarriage.
Over half of the UK's regional genetics laboratories and more than 100 of the world's leading hospitals use Bluegnome's current Cytochip test, which provides high-resolution and automated screening of DNA samples for abnormalities associated with leukaemias and childhood developmental delay.
